ClinConnect ClinConnect Logo
Search / Trial NCT04472208

AMS Evaluation Study

Launched by GE HEALTHCARE · Jul 10, 2020

Trial Information

Current as of August 02, 2025

Completed

Keywords

ClinConnect Summary

The study is going to be conducted to collect feedback from the users about operation of AMS collect parameter raw data from patients in hospital ward setting using the investigational system for use in current and future AMS engineering and regulatory purposes as deemed appropriate by the Sponsor.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Male or female aged 18 years or older (≥18 years);
  • 2. Able and willing to provide written informed consent independently.
  • Exclusion Criteria:
  • 1. Have previously participated in this study (no subject may participate more than once);
  • 2. Have an implantable pacemaker;
  • 3. Diagnosed with infection requiring isolation; OR
  • 4. Known to be pregnant and/or breast feeding;

About Ge Healthcare

GE Healthcare is a leading global medical technology and digital solutions innovator, dedicated to improving patient outcomes through advanced imaging, monitoring, and diagnostics. With a commitment to enhancing healthcare delivery, GE Healthcare develops cutting-edge technologies and clinical applications that empower healthcare professionals to make informed decisions. By leveraging extensive research and development capabilities, the organization actively sponsors clinical trials aimed at validating new therapies and medical devices, ensuring that they meet the highest standards of safety and efficacy. Through collaboration with healthcare providers and institutions, GE Healthcare strives to drive innovation and improve the efficiency of healthcare systems worldwide.

Locations

London, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Meera Joshi, MBBS

Principal Investigator

St. Marys Hospital, London

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials